Francois Maisonrouge
Président chez Pasteur Foundation
Profil
Francois Maisonrouge is currently the Chairman of Pasteur Foundation and a Director at Équilibre BioPharmaceuticals Corp.
He previously worked as the Chairman & Managing Director at Credit Suisse Securities (USA) LLC and as a Senior Managing Director at Evercore, Inc. Maisonrouge holds an MBA from Harvard University and a graduate degree from Ecole Centrale Lyon.
Postes actifs de Francois Maisonrouge
| Sociétés | Poste | Début |
|---|---|---|
Équilibre BioPharmaceuticals Corp.
 Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Directeur/Membre du Conseil | - |
Pasteur Foundation
 Pasteur Foundation Miscellaneous Commercial ServicesCommercial Services Pasteur Foundation operates as a research center. The private company is based in New York, NY. | Président | - |
Anciens postes connus de Francois Maisonrouge
| Sociétés | Poste | Fin |
|---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Président | - |
| EVERCORE INC. | Corporate Officer/Principal | - |
Formation de Francois Maisonrouge
| Ecole Centrale Lyon | Graduate Degree |
| Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EVERCORE INC. | Finance |
| Entreprise privées | 3 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
Équilibre BioPharmaceuticals Corp.
Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Health Technology |
Pasteur Foundation
Pasteur Foundation Miscellaneous Commercial ServicesCommercial Services Pasteur Foundation operates as a research center. The private company is based in New York, NY. | Commercial Services |
